Is 10Rx Legit? Quarterly Pricing and Pharmacy Options Reviewed

Last reviewed: September 6, 2026 Last updated: September 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

10Rx operates as a telehealth compounded-GLP-1 provider with a quarterly prepaid pricing model: $299 every three months for compounded semaglutide ($99.67/month prepaid equivalent) and $450 every three months for compounded tirzepatide ($150/month prepaid equivalent), verified September 4, 2026. The quarterly packages include medication, clinician evaluation, next-day shipping, and support with no add-on fees; pricing is flat across all available strengths. The provider notes that "pharmacy options vary" but does not specify 503A or outsourcing-facility sourcing in the captured disclosures. No Trustpilot profile was located, and Reddit searches yielded one thread reference with no extractable negative themes—so independent service-quality evidence is sparse. The prepaid structure delivers the lowest per-month GLP-1 rates we have documented, but it requires $299 or $450 upfront every quarter and offers no public review track record for prospective patients to evaluate.

At-a-glance comparison

Pricing breakdown and 12-month cost

10Rx quarterly prepaid model

10Rx charges $299 upfront for three months of compounded semaglutide with B12, or $450 upfront for three months of compounded tirzepatide with B12 (captured September 4, 2026 from take10rx.com/pricing). Each quarterly package includes the medication, clinician evaluation, next-day shipping, and ongoing support—no separate visit fees, membership charges, or shipping add-ons. The provider maintains flat pricing across all available strengths within each compound, so a patient starting at a lower dose pays the same quarterly rate as someone titrated to a higher maintenance dose.

Evidence note: The primary pricing page confirms the quarterly flat-strength structure and all inclusions but suppresses numeric totals; the $299 semaglutide and $450 tirzepatide figures are secondary corroboration and carry mixed-primary-secondary verification status. The quarterly prepay commitment and inclusion list are verified from the primary source.

12-month cost (our calculation):

• Semaglutide: $299 per quarter × 4 quarters = $1,196/year ($99.67/month prepaid equivalent)
• Tirzepatide: $450 per quarter × 4 quarters = $1,800/year ($150/month prepaid equivalent)

The prepaid structure means patients commit $299 or $450 every three months; there is no option to pay monthly or pause without forfeiting the remainder of a prepaid quarter.

PlexusDx month-to-month pricing

PlexusDx charges $189/month for compounded semaglutide injection and $289/month for compounded tirzepatide injection on a month-to-month basis (verified July 2026). No membership fee, no quarterly commitment, and the same per-month rate at every dose. Each month includes the medication, a licensed provider visit, and shipping; patients can pause or discontinue without upfront financial exposure beyond the current month.

12-month cost (our calculation):

• Semaglutide: $189/month × 12 = $2,268/year
• Tirzepatide: $289/month × 12 = $3,468/year

Like-for-like comparison over 12 months

All 12-month totals are our calculation. 10Rx requires full quarterly prepayment ($299 or $450 every three months); PlexusDx bills monthly with no upfront commitment.

Pharmacy options and compounded-medication disclosure

10Rx states that "pharmacy options vary" but does not specify 503A or outsourcing-facility sourcing in the captured disclosures (September 4, 2026). The phrase suggests the provider may work with multiple pharmacies or that pharmacy assignment varies by patient geography or medication availability, but no further detail appears on the public pricing page. Patients seeking clarity on which pharmacy will fulfill their prescription should confirm the specific pharmacy name and regulatory classification during the intake or consultation process.

PlexusDx works exclusively with licensed 503A compounding pharmacies.

Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Review record and service-quality signals

We searched Trustpilot and Reddit for independent 10Rx reviews on September 4, 2026. No Trustpilot profile was located. A Reddit search identified one discussion thread (r/tirzepatidecompound) mentioning 10Rx, but no attributable patient reports, complaint themes, or service-quality anecdotes were extracted from that thread. The absence of a public review presence means prospective patients have no independent third-party feedback to evaluate responsiveness, shipping reliability, or support quality before committing to a quarterly prepayment.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026).

Decision factors: quarterly prepay vs. monthly flexibility

10Rx strengths

• Lowest documented per-month equivalent: $99.67/month prepaid for semaglutide and $150/month prepaid for tirzepatide are the lowest GLP-1 rates in our comparison set—$1,072 and $1,668 lower than PlexusDx over 12 months, respectively (our calculation).
• Flat quarterly pricing: One prepaid rate covers all available strengths within each compound, so titration does not trigger a price increase.
• All-inclusive packages: Medication, clinician evaluation, next-day shipping, and support bundled with no add-on fees.

10Rx gaps and unknowns

• No public review record: Zero Trustpilot presence and no extractable Reddit feedback mean no independent evidence on support responsiveness, shipping consistency, or patient satisfaction.
• Quarterly prepay commitment: $299 or $450 must be paid upfront every three months; no monthly option or mid-quarter pause without forfeiting the prepaid balance.
• Vague pharmacy disclosure: "Pharmacy options vary" does not specify 503A or outsourcing-facility sourcing or identify which pharmacies patients will receive medication from.
• Evidence quality: The quarterly structure and inclusions are verified from the primary source, but the $299/$450 dollar totals are secondary corroboration—patients should confirm totals at checkout.

PlexusDx strengths

• Month-to-month billing: No quarterly prepayment; patients can pause or discontinue after any month without upfront financial exposure.
• Verified review record: 4.3-star Trustpilot rating with 83% of reviews at four stars or higher provides independent service-quality evidence.
• Transparent 503A sourcing: Works exclusively with licensed 503A compounding pharmacies, disclosed in every patient communication.
• Flat dose pricing: $189/month semaglutide, $289/month tirzepatide at every dose—no surprises during titration.

PlexusDx gaps

• Higher 12-month cost: Month-to-month pricing totals $1,072 more for semaglutide and $1,668 more for tirzepatide over 12 months than 10Rx's prepaid quarterly model (our calculation).

Choose 10Rx if…

• You are certain you will continue GLP-1 therapy for at least the next three months and can commit $299 (semaglutide) or $450 (tirzepatide) upfront every quarter.
• Minimizing total annual cost is your top priority, and you accept the lack of public review evidence in exchange for the lowest documented per-month rate.
• You do not require monthly billing flexibility or the ability to pause without forfeiting prepaid funds.
• You are comfortable confirming pharmacy sourcing (503A or outsourcing facility) during intake, since the public disclosure is vague.

Choose PlexusDx if…

• You prefer month-to-month billing with no quarterly prepayment—pause or stop after any month without upfront financial commitment.
• You want independent service-quality evidence before selecting a provider; PlexusDx's 4.3-star Trustpilot rating and 83% four-star-or-higher review share provide third-party feedback on responsiveness and reliability.
• You value transparent 503A pharmacy sourcing disclosed upfront rather than a "pharmacy options vary" statement.
• You are willing to pay $1,072 more (semaglutide) or $1,668 more (tirzepatide) over 12 months for billing flexibility and an established review track record (our calculation).

Methodology and freshness

We captured 10Rx pricing, inclusions, and pharmacy disclosures from take10rx.com/pricing on September 4, 2026. The quarterly prepaid structure, flat-strength pricing, and inclusion list (medication, clinician evaluation, next-day shipping, support) are verified from the primary source; the $299 semaglutide and $450 tirzepatide quarterly totals are secondary corroboration and carry mixed-primary-secondary verification status. We searched Trustpilot and Reddit for independent reviews on September 4, 2026; no Trustpilot profile was located, and one Reddit thread reference yielded no extractable patient feedback. PlexusDx pricing was verified July 17–23, 2026, and the Trustpilot rating was captured September 4, 2026. All 12-month cost comparisons and per-month prepaid equivalents are our calculation, derived by multiplying quarterly or monthly rates by the appropriate billing cycles. We did not submit payment to either provider; patients should confirm final totals, pharmacy assignments, and refill terms at checkout.

Frequently Asked Questions

Is 10Rx a legitimate compounded GLP-1 provider?

10Rx operates a documented telehealth service with verified pricing structure ($299/quarter semaglutide, $450/quarter tirzepatide), all-inclusive packages, and a flat-strength pricing policy captured September 4, 2026. However, no Trustpilot profile or extractable Reddit reviews were located, so independent service-quality evidence is absent. The provider notes "pharmacy options vary" but does not specify 503A or outsourcing-facility sourcing in public disclosures.

What is the real monthly cost of 10Rx after the first quarter?

10Rx charges the same rate every quarter: $299 prepaid for three months of semaglutide ($99.67/month prepaid equivalent) or $450 prepaid for three months of tirzepatide ($150/month prepaid equivalent). There is no separate "refill" rate—the quarterly total remains flat across all billing cycles and all available strengths within each compound, verified September 4, 2026.

Can I pay monthly instead of quarterly with 10Rx?

No monthly billing option is documented in the captured sources (September 4, 2026). The service operates on a quarterly prepaid model only, requiring $299 (semaglutide) or $450 (tirzepatide) upfront every three months. Patients seeking month-to-month billing with no quarterly commitment should evaluate providers that offer monthly cycles, such as PlexusDx ($189/month semaglutide, $289/month tirzepatide).

Does 10Rx use 503A or outsourcing-facility compounding pharmacies?

10Rx states "pharmacy options vary" but does not specify 503A or outsourcing-facility regulatory classification in the captured public disclosures (September 4, 2026). Patients should request the specific pharmacy name and regulatory status during intake or consultation. PlexusDx discloses upfront that it works exclusively with licensed 503A compounding pharmacies.

How does 10Rx pricing compare to PlexusDx over a full year?

Over 12 months, 10Rx totals $1,196 for semaglutide (quarterly prepaid) versus PlexusDx $2,268 (month-to-month), a difference of $1,072; tirzepatide totals $1,800 (10Rx) versus $3,468 (PlexusDx), a difference of $1,668 (our calculation). The 10Rx advantage requires four quarterly prepayments of $299 or $450 with no monthly flexibility; PlexusDx bills monthly with no upfront commitment and holds a 4.3-star Trustpilot rating.

Sources

• 10Rx pricing and inclusions captured from take10rx.com/pricing, September 4, 2026
• PlexusDx pricing verified July 17–23, 2026
• PlexusDx Trustpilot rating captured September 4, 2026
• Trustpilot and Reddit review searches performed September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.